Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1875.69 (Glytoucan)

Id:c8ecec51-8789-5de3-92a3-c861c39a2e09

Glytoucan:G47702MW

Results found

Linked to

	Label	Description
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G32639VU-GLYCOSEQ00134077 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has motif Blood group H (type 2) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has canonical residue n-glycan core d-glcnac a Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G60771OS-GLYCOSEQ00117723 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G20180GO-GLYCOSEQ00034081 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G14029LK-GLYCOSEQ00135145 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G55348TP-GLYCOSEQ00180751 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G48400CZ-GLYCOSEQ00128299 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G32639VU-GLYCOSEQ00134077 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has motif Blood group H (type 2)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has canonical residue n-glycan core d-glcnac a

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G60771OS-GLYCOSEQ00117723 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G20180GO-GLYCOSEQ00034081 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G14029LK-GLYCOSEQ00135145 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G55348TP-GLYCOSEQ00180751 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1875.69 has glycosequence GLYGEN.GLYCOSEQUENCE:G48400CZ-GLYCOSEQ00128299 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.